A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma

Rebecca Amet(Trinity College Dublin), Daniela M. Zisterer(Trinity College Dublin)

Life Sciences

December 22, 2021

10.1016/j.lfs.2021.120236

Cited by 2

Related Papers

Inhibition of γ-secretase activity synergistically enhances tumour necrosis factor-related apoptosis-inducing ligand induced apoptosis in T-cell acute lymphoblastic leukemia cells via upregulation of death receptor 5

|Oncology Letters|2016|7